World's Best Scientists 2026 revealed!
Jeffrey I. Weitz

Jeffrey I. Weitz

D-Index & Metrics

Medicine

D-Index
136
Citations
94765
World Ranking
1943
National Ranking
71

Jeffrey I. Weitz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jeffrey I. Weitz sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 693 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jeffrey I. Weitz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jeffrey I. Weitz sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 136 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2016 - Fellow of the Royal Society of Canada Academy of Science
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Jeffrey I. Weitz is affiliated with McMaster University in Canada and has a significant body of research in the field of medicine, particularly focusing on cardiology and cardiovascular medicine, internal medicine, and hematology. Their work spans multiple subfields including genetics and surgery, demonstrating a broad expertise across medical disciplines.

The primary research topics addressed by Weitz include:

  • Venous Thromboembolism Diagnosis and Management
  • Atrial Fibrillation Management and Outcomes
  • Blood Coagulation and Thrombosis Mechanisms
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Antiplatelet Therapy and Cardiovascular Diseases
  • COVID-19 Clinical Research Studies
  • Acute Myocardial Infarction Research

Among recent papers associated with the scientific community around Weitz are key publications including:

  • COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up, 2020, Journal of the American College of Cardiology
  • Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19, 2021, JAMA Internal Medicine
  • Therapeutic strategies for thrombosis: new targets and approaches, 2020, Nature Reviews Drug Discovery
  • Abelacimab for Prevention of Venous Thromboembolism, 2021, New England Journal of Medicine
  • Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research, 2020, Thrombosis and Haemostasis

Frequently collaborating with other researchers, Weitz has coauthored publications alongside:

  • Walter Ageno
  • Samuel Z. Goldhaber
  • James C. Fredenburgh
  • Shinya Goto
  • Pantep Angchaisuksiri

Weitz's work commonly appears in journals such as:

  • Journal of Thrombosis and Haemostasis
  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Thrombosis and Haemostasis
  • Research and Practice in Thrombosis and Haemostasis
  • Thrombosis Research

Notable recognitions in their career include being named a Fellow of the Royal Society of Canada in 2016, within the Academy of Science, and membership in the Association of American Physicians.

Best Publications

  • Edoxaban versus warfarin in patients with atrial fibrillation

    Robert P. Giugliano;Christian T. Ruff;Eugene Braunwald;Sabina A. Murphy

  • Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

    Christian T Ruff;Robert P Giugliano;Eugene Braunwald;Elaine B Hoffman

  • COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

    Behnood Bikdeli;Mahesh V. Madhavan;David Jimenez;Taylor Chuich

  • Oral Apixaban for the Treatment of Acute Venous Thromboembolism

    Giancarlo Agnelli;Harry R. Buller;Alexander Cohen;Madelyn Curto

  • Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer

    Philip S. Wells;David R. Anderson;Marc Rodger;Jeffrey S. Ginsberg

  • Low-Molecular-Weight Heparins

    Jeffrey I. Weitz

  • Idarucizumab for Dabigatran Reversal

    Charles V. Pollack;Paul A. Reilly;John Eikelboom;Stephan Glund

  • A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.

    Mark Levine;Michael Gent;Jack Hirsh;Jacques Leclerc

  • Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events

    John W. Eikelboom;Jack Hirsh;Jeffrey I. Weitz;Marilyn Johnston

  • Apixaban for Extended Treatment of Venous Thromboembolism

    Giancarlo Agnelli;Harry R. Buller;Alexander Cohen;Madelyn Curto

  • Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

    Gary E. Raskob;Nick van Es;Peter Verhamme;Marc Carrier

  • A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

    Clive Kearon;Michael Gent;Michael Gent;Jack Hirsh;Jack Hirsh;Jeffrey Weitz

  • Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.

    J I Weitz;M Hudoba;D Massel;J Maraganore

  • Use of a clinical model for safe management of patients with suspected pulmonary embolism.

    Philip S. Wells;Jeffrey S. Ginsberg;David R. Anderson;Clive Kearon

  • Diagnosis and Treatment of Chronic Arterial Insufficiency of the Lower Extremities: A Critical Review

    Weitz Ji;Byrne J;Clagett Gp;Farkouh Me

  • Parenteral Anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

    David A. Garcia;Trevor P. Baglin;Jeffrey I. Weitz;Meyer Michel Samama

  • Thrombosis A Major Contributor to Global Disease Burden

    G.E. Raskob;P. Angchaisuksiri;A.N. Blanco;H. Buller

  • Comparison of Low-Intensity Warfarin Therapy With Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism

    Clive Kearon;Jeffrey S. Ginsberg;Michael J. Kovacs;David R. Anderson

  • Idarucizumab for Dabigatran Reversal — Full Cohort Analysis

    Charles V. Pollack;Paul A. Reilly;Joanne van Ryn;John W. Eikelboom

  • Accuracy of clinical assessment of deep-vein thrombosis

    PhilipS. Wells;Jack Hirsh;DavidR. Anderson;AnthonyW.A. Lensing

Frequent Co-Authors

John W. Eikelboom
John W. Eikelboom Population Health Research Institute
Jack Hirsh
Jack Hirsh McMaster University
Gary E. Raskob
Gary E. Raskob University of Oklahoma Health Sciences Center
Harry R. Büller
Harry R. Büller University of Amsterdam
Jeffrey S. Ginsberg
Jeffrey S. Ginsberg McMaster University
Alexander G.G. Turpie
Alexander G.G. Turpie McMaster University
Walter Ageno
Walter Ageno University of Insubria
Paolo Prandoni
Paolo Prandoni University of Padua
Philip S. Wells
Philip S. Wells Ottawa Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine doesn’t have to be limited by traditional, in-person degrees. Aspiring healthcare professionals can find a variety of online programs designed to fit different goals and schedules. For instance, if you're looking to advance your nursing career quickly, consider the shortest dnp programs online that let you earn a Doctor of Nursing Practice degree on an accelerated timeline.

For those seeking a more manageable academic workload, easiest dnp program online options can make advancing your credentials more accessible. If you’re starting out, lpn programs offer a fast track into nursing, allowing you to begin working in the medical field sooner.

Nurses with a BSN can also find advanced specialized pathways. Consider bsn to np programs online for opportunities to become a nurse practitioner, opening doors to high-demand specialties like psychiatric and mental health.

No matter your background or professional goals, online degrees can provide flexible, efficient routes into fulfilling healthcare careers.

Best Scientists Citing Jeffrey I. Weitz

Trending Scientists

Recently Published Articles